Schultz-Klarr S, Wright-Richey J, Dunbar J C
Department of Physiology, Wayne State University, School of Medicine, Detroit, MI 48201.
Diabetes Res Clin Pract. 1994 Dec 16;26(2):81-9. doi: 10.1016/0168-8227(94)90144-9.
To determine the possibility that insulin and/or glucose may directly or indirectly modulate cardiovascular tone, we measured plasma glucose, arterial pressure and heart rate after the injection of insulin, 2-deoxyglucose (2-DG) and glucose into the femoral vein or into the lateral ventricles of Wistar rats. The systemic administration of insulin significantly decreased plasma glucose, while its intracerebroventricular (ICV) infusion had little effect on plasma glucose, although it resulted in a significant increase in plasma insulin. Both the peripheral and the ICV administration of insulin significantly decreased mean arterial pressure (MAP) and ICV insulin decreased heart rate. Injections of 2-deoxyglucose were used to help differentiate the effects of insulin from those of insulin-induced glucopenia. When infused systemically, 2-DG increased plasma glucose while ICV 2-DG had no significant effect on plasma glucose levels. When 2-DG was administered systemically, MAP and heart rate were increased slightly; however, they were significantly decreased when 2-DG was administered centrally. Both ICV and systemic administration of glucose increased plasma insulin even though ICV glucose did not significantly change the plasma glucose level. Both systemic and ICV administration of glucose significantly decreased MAP and heart rate. These results suggest that increasing the insulin and/or glucose concentration of the CNS environment may have a direct influence on autonomic outflow resulting in decreased MAP and heart rate. Central glucopenia induced by 2-DG suppressed sympathetic or increased parasympathetic outflow, while systemic glucopenia stimulated cardiovascular tone. Both systemic and central glucose administration suppressed the cardiovascular tone to a lesser extent than did administration of insulin.(ABSTRACT TRUNCATED AT 250 WORDS)
为了确定胰岛素和/或葡萄糖可能直接或间接调节心血管张力的可能性,我们在向Wistar大鼠的股静脉或侧脑室注射胰岛素、2-脱氧葡萄糖(2-DG)和葡萄糖后,测量了血浆葡萄糖、动脉血压和心率。胰岛素的全身给药显著降低了血浆葡萄糖,而其脑室内(ICV)注入对血浆葡萄糖影响不大,尽管它导致血浆胰岛素显著增加。胰岛素的外周和ICV给药均显著降低了平均动脉压(MAP),且ICV胰岛素降低了心率。注射2-脱氧葡萄糖有助于区分胰岛素的作用与胰岛素诱导的低血糖的作用。全身输注时,2-DG可增加血浆葡萄糖,而ICV 2-DG对血浆葡萄糖水平无显著影响。2-DG全身给药时,MAP和心率略有增加;然而,当2-DG中枢给药时,它们显著降低。ICV和全身给予葡萄糖均增加了血浆胰岛素,尽管ICV葡萄糖并未显著改变血浆葡萄糖水平。葡萄糖的全身和ICV给药均显著降低了MAP和心率。这些结果表明,增加中枢神经系统环境中的胰岛素和/或葡萄糖浓度可能直接影响自主神经输出,导致MAP和心率降低。2-DG诱导的中枢低血糖抑制交感神经或增加副交感神经输出,而全身低血糖则刺激心血管张力。与胰岛素给药相比,全身和中枢给予葡萄糖对心血管张力的抑制作用较小。(摘要截断于250字)